- Ibuprofen
- Aspirin
- Paracetmol
- Diclofenac
- Others
NSAIDs API Market size was valued at USD x billion in 2021 and is expected to grow at a CAGR of x% from 2022-2028.owing to increase in prevalence of arthritis, which is the major cause for the disability and growing number of geriatric population across the globe drives the growth of the market. For instance, According to Center for Disease Control and Prevention (CDC), from 2013-2015, approximately 54.4 Mn US adults had some form of arthritis such as gout, rheumatoid arthritis treatment, fibromyalgia, and lupus and estimated to reach 78 Mn adults aged 18 years older are projected to have arthritis by 2040.  NSAIDs are drug class that groups together drugs that provide analgesic and anti-pyretic effects. Moreover, increasing access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating positive impact on NSAID market. However, availability of alternative products in the market for NSAIDs and development of advanced medications are expected to hamper the growth of the market. This report studies Global NSAIDs API market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Global NSAIDs API market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global NSAIDs API market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Global NSAIDs API.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Low cost of the non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, piroxicam, aspirin, and other drugs coupled with the better availability of the products boost the revenue growth of global NSAIDs market over the forecast years. Formulation of NSAIDs for the patient convenience also enhance the market revenue in the forthcoming years. For instance, Pfizer, Inc. marketing the Flector (Diclofenac Epolamine Topical Patch) to treat acute pain due to minor strains, sprains, and bruises. In addition, NSAIDs also available in the injectable forms which are easy to administer the patients unable to swallow the tablets. Moreover, Mylan laboratories manufacturing Brufen effervescent granules that can be easily administered for the geriatric and paediatric patients
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.